- Filed
- May 29, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 26, 2026 | 6.37M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 6.37M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 6.18M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.14M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.6M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.1M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.93M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $11.38M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $6.77M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.46M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $3.89M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $10.66M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $10.12M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $3.53M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $4.62M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $12.76M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $14.04M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.29 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.49 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.29 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.49 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.29M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $2.22M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $312K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $808K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.83M |
| Net Income | Q1 2026 · Mar 31, 2025 | $3.01M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.64M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $2.92M |
| Revenue | Q1 2026 · Mar 31, 2026 | $0 |
| Revenue | Q1 2026 · Mar 31, 2025 | $0 |